Table 3.

Number of adverse events within 90 days after primary total hip replacement (THR) among propensity score matched patients who were eligible for red blood cell transfusion.

	Propensity score matching model
Outcome	Transfusion n = 2,254	Non-transfusion n = 2,254
Death	39 (1.7%)	18 (0.8%)
Cardiovascular or cerebrovascular disease	54 (2.4%)	39 (1.7%)
Deep venous thrombosis and/or pulmonary embolism	28 (1.2%)	23 (1.0%)
Pneumonia	36 (1.6%)	17 (0.8%)
Reoperation due to Infection of THR	5 (0.2%)	5 (0.2%)